These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16803510)

  • 1. Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system.
    Tawfik El-Mansi M; Williams AR
    Int J Gynecol Cancer; 2006; 16(3):1225-33. PubMed ID: 16803510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the residual of cervical thin layer brush samples through cytohistology in cases with invasive carcinoma with application of antibodies.
    Risse EK; Ouwerkerk-Noordam E; Meijer-Marres EM; Boon ME
    Acta Cytol; 2010; 54(2):175-82. PubMed ID: 20391974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of PTEN expression in cervical adenocarcinoma by tissue microarray.
    El-Mansi MT; Williams AR
    Int J Gynecol Cancer; 2006; 16(3):1254-60. PubMed ID: 16803514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus.
    Boone J; van Hillegersberg R; van Diest PJ; Offerhaus GJ; Rinkes IH; Kate FJ
    Virchows Arch; 2008 May; 452(5):507-14. PubMed ID: 18392848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
    Jones MW; Onisko A; Dabbs DJ; Elishaev E; Chiosea S; Bhargava R
    Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
    Han CP; Kok LF; Lee MY; Wu TS; Ruan A; Cheng YW; Wang PH; Koo CL; Tyan YS
    Arch Gynecol Obstet; 2010 Feb; 281(2):317-23. PubMed ID: 19444461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
    Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
    J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Hsu JD; Yao CC; Lee MY; Kok LF; Wang PH; Tyan YS; Han CP
    Int J Gynecol Pathol; 2010 May; 29(3):282-9. PubMed ID: 20407331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ adenocarcinoma and squamous carcinoma of uterine cervix. Pathological and immunohistochemical analysis with cytokeratin 13.
    Raspollini MR; Fambrini M; Marchionni M; Baroni G; Taddei GL
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):249-53. PubMed ID: 16949723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the levels of CA125, carcinoembryonic antigen, and CA19-9 in the cervical mucus for a detection of cervical adenocarcinoma.
    Fujii S; Konishi I; Nanbu Y; Nonogaki H; Kobayashi F; Sagawa N; Mori T; Endo K
    Cancer; 1988 Aug; 62(3):541-7. PubMed ID: 2455590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.
    Alkushi A; Irving J; Hsu F; Dupuis B; Liu CL; Rijn M; Gilks CB
    Virchows Arch; 2003 Mar; 442(3):271-7. PubMed ID: 12647218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of tissue array technology in head and neck squamous cell carcinoma.
    Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
    Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a tissue microarray with two millimeters cores of endometrioid endometrial cancer: factors affecting the quality of the recipient block.
    Gottwald L; Sęk P; Piekarski J; Pasz-Walczak G; Kubiak R; Szwalski J; Spych M; Suzin J; Tyliński W; Topczewska-Tylinska K; Jeziorski A
    Biotech Histochem; 2012 Nov; 87(8):512-8. PubMed ID: 22909182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
    Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.
    Berlth F; Mönig SP; Schlösser HA; Maus M; Baltin CT; Urbanski A; Drebber U; Bollschweiler E; Hölscher AH; Alakus H
    Anticancer Res; 2014 Jul; 34(7):3313-20. PubMed ID: 24982335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
    Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An agarose matrix facilitates sectioning of tissue microarray blocks.
    Yan P; Seelentag W; Bachmann A; Bosman FT
    J Histochem Cytochem; 2007 Jan; 55(1):21-4. PubMed ID: 16899763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of tissue micro array from prostate needle biopsies using the vertical clustering re-arrangement technique.
    Fridman E; Daya D; Srigley J; Whelan KF; Lu JP; Pinthus JH
    Prostate; 2011 Sep; 71(13):1374-81. PubMed ID: 21308718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Andersen J; Overgaard J
    Acta Oncol; 2008; 47(4):591-9. PubMed ID: 18465327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.